NDC 50090-5139

Ozempic

Semaglutide

Ozempic is a Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by A-s Medication Solutions. The primary component is Semaglutide.

Product ID50090-5139_c4869820-1a83-42b5-8ba0-46fa98e373fd
NDC50090-5139
Product TypeHuman Prescription Drug
Proprietary NameOzempic
Generic NameSemaglutide
Dosage FormInjection, Solution
Route of AdministrationSUBCUTANEOUS
Marketing Start Date2017-12-06
Marketing CategoryNDA / NDA
Application NumberNDA209637
Labeler NameA-S Medication Solutions
Substance NameSEMAGLUTIDE
Active Ingredient Strength1 mg/mL
Pharm ClassesGLP-1 Receptor Agonist [EPC],Glucagon-Like Peptide 1 [CS],Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 50090-5139-0

2 SYRINGE, PLASTIC in 1 CARTON (50090-5139-0) > 1.5 mL in 1 SYRINGE, PLASTIC
Marketing Start Date2020-08-31
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Ozempic" or generic name "Semaglutide"

NDCBrand NameGeneric Name
0169-4130Ozempicsemaglutide
0169-4132Ozempicsemaglutide
0169-4136Ozempicsemaglutide
0169-4181Ozempicsemaglutide
0169-4772Ozempicsemaglutide
50090-5138Ozempicsemaglutide
50090-5139Ozempicsemaglutide
70518-2143OzempicOzempic
0169-4501WEGOVYsemaglutide
0169-4505WEGOVYsemaglutide
0169-4517WEGOVYsemaglutide
0169-4524WEGOVYsemaglutide
0169-4525WEGOVYsemaglutide

Trademark Results [Ozempic]

Mark Image

Registration | Serial
Company
Trademark
Application Date
OZEMPIC
OZEMPIC
79159431 4774881 Live/Registered
Novo Nordisk A/S
2014-12-03

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.